Philips shares soar on $1.1bn DOJ settlement

Koninklijke Philips, the Dutch healthcare giant, has finally reached a settlement with US regulators over a Respironics product recall back in 2021 worth $1.1bn, causing shares to soar by more than a third on Monday morning.

Related Keywords

China , Amsterdam , Noord Holland , Netherlands , Roy Jakobs , Drug Administration , Department Of Justice , Philips , Respironics , Shares , Soar , 46 1bn , Settlement , Category All , Category Company News , Category News And Announcements , Category International Companies , Category Sectorial Producer Manufacturing ,